BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 37172497)

  • 1. Therapeutic approach to central nervous system involvement of Behçet's disease.
    Sota J; Capuano A; Emmi G; Iannone F; Cantarini L; Hatemi G; Lopalco G
    Semin Arthritis Rheum; 2023 Aug; 61():152206. PubMed ID: 37172497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and disease course of neurological involvement in Behcet's disease: HUVAC experience.
    Bolek EC; Sari A; Kilic L; Kalyoncu U; Kurne A; Oguz KK; Topcuoglu MA; Ertenli I; Karadag O
    Mult Scler Relat Disord; 2020 Feb; 38():101512. PubMed ID: 31733425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent aspects of Neuro-Behcet's disease].
    Hirohata S
    Brain Nerve; 2013 Nov; 65(11):1245-53. PubMed ID: 24200602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposing an algorithm for treatment of different manifestations of neuro-Behcet's disease.
    Borhani Haghighi A; Safari A
    Clin Rheumatol; 2010 Jun; 29(6):683-6. PubMed ID: 20229137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of neurological manifestations of Behçet's disease: a retrospective monocentric study in Tunisia.
    Houman MH; Bellakhal S; Ben Salem T; Hamzaoui A; Braham A; Lamloum M; Monia SK; Ben Ghorbel I
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2015-8. PubMed ID: 23830180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behçet's Disease.
    Akman-Demir G; Saip S; Siva A
    Curr Treat Options Neurol; 2011 Jun; 13(3):290-310. PubMed ID: 21416331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab therapy in parenchymal neuro-Behçet's disease: A single-center experience.
    Yalcin Kehribar D; Gunaydin S; Ozgen M
    Int J Rheum Dis; 2021 Oct; 24(10):1302-1307. PubMed ID: 34427044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case of neuro-Behçet's disease successfully maintained a remission using infliximab for 2 years.
    Kanemaru H; Makino T; Jinnin M; Yonemitsu A; Makino K; Ihn H
    J Dermatol; 2013 Aug; 40(8):632-4. PubMed ID: 23724912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial involvement in Behçet's disease may be higher in patients with Neuro-Behçet's disease: a speckle tracking echocardiographic study.
    Sunbul M; Midi IG; Agackiran SK; Engin E; Ucem S; Alibaz-Oner F; Sayar N; Direskeneli H; Sadıc BO
    Acta Cardiol; 2022 Aug; 77(6):515-523. PubMed ID: 34392811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet's Disease.
    Yan D; Liu J; Zhang Y; Yuan W; Xu Y; Shi J; Li C; Wang Y; Peng L; Yang Y; Zhou J; Wu D; Liu Z; Zeng X; Zhang F; Zheng W; Zhao Y
    J Immunol Res; 2019; 2019():7371458. PubMed ID: 31612152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the Treatment of Behcet's Disease.
    Alibaz-Oner F; Direskeneli H
    Curr Rheumatol Rep; 2021 May; 23(6):47. PubMed ID: 34014377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical and radiological features and prevalence of Neuro-Behçet's Disease: A retrospective cohort multicenter study in Saudi Arabia.
    Makkawi S; Aljafari D; Alsharif R; Maaddawi H; Alwagdani A; Aljumah T; Alghweinem Z; Alshehri S; Khojah O; Halawani A; Ahmed Adas R; Abulaban A; Al Malik Y
    Mult Scler Relat Disord; 2024 May; 85():105558. PubMed ID: 38569381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lesion distribution pattern of parenchymal Neuro-Behçet's disease using probability mapping.
    Emekli AS; Ersözlü E; Emekli MA; Gündüz T; Kürtüncü M
    Mult Scler Relat Disord; 2022 Feb; 58():103457. PubMed ID: 34929453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of neuro-Behçet's disease: an update.
    Borhani Haghighi A
    Expert Rev Neurother; 2009 Apr; 9(4):565-74. PubMed ID: 19344307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuro-Behcet's disease: An update on diagnosis, differential diagnoses, and treatment.
    Borhani-Haghighi A; Kardeh B; Banerjee S; Yadollahikhales G; Safari A; Sahraian MA; Shapiro L
    Mult Scler Relat Disord; 2020 Apr; 39():101906. PubMed ID: 31887565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of neurological and ocular symptoms of Behçet's disease after the introduction of infliximab.
    Barešić M; Reihl M; Habek M; Vukojević N; Anić B
    Rheumatol Int; 2018 Jul; 38(7):1301-1306. PubMed ID: 29777341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Headache in Behçet's and Neuro-Behçet's Disease.
    Beton OE; Yucesan C
    Neurol India; 2022; 70(1):254-257. PubMed ID: 35263891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for the management of oral ulcers in Behçet's disease.
    Taylor J; Glenny AM; Walsh T; Brocklehurst P; Riley P; Gorodkin R; Pemberton MN
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD011018. PubMed ID: 25254615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuro-behçet's disease in South Korea: clinical characteristics and treatment response.
    Yoon DL; Kim YJ; Koo BS; Kim YG; Lee CK; Yoo B
    Int J Rheum Dis; 2014 May; 17(4):453-8. PubMed ID: 24506839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutritional Status in patients with Neuro-Behçet's disease.
    Erdoğan S; Sorgun MH; Kuzu Mumcu M; Kural MA; Rzayev S; Yücesan C
    Turk J Med Sci; 2021 Aug; 51(4):1682-1688. PubMed ID: 33600096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.